These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7568552)

  • 1. Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine.
    Fava M; Giannelli A; Rapisarda V; Patralia A; Guaraldi GP
    Psychiatry Res; 1995 Apr; 56(3):295-7. PubMed ID: 7568552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R; Pancheri P; Scapicchio P
    Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.
    Bressa GM
    Acta Neurol Scand Suppl; 1994; 154():7-14. PubMed ID: 7941964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine.
    Berlanga C; Ortega-Soto HA; Ontiveros M; Senties H
    Psychiatry Res; 1992 Dec; 44(3):257-62. PubMed ID: 1289923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [S-Adenosyl-L-methionine. Latest results on its efficacy as an antidepressive agent].
    Ortiz P
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1988; 16(3):201-3. PubMed ID: 3218569
    [No Abstract]   [Full Text] [Related]  

  • 9. The antidepressant potential of oral S-adenosyl-l-methionine.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Acta Psychiatr Scand; 1990 May; 81(5):432-6. PubMed ID: 2113347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring S-adenosyl-methionine blood levels and antidepressant effect.
    Del Vecchio M; Amati A; Vacca L; Zizolfi S
    Acta Neurol (Napoli); 1980 Dec; 2(6):488-95. PubMed ID: 7027755
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.
    Salmaggi P; Bressa GM; Nicchia G; Coniglio M; La Greca P; Le Grazie C
    Psychother Psychosom; 1993; 59(1):34-40. PubMed ID: 8441793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant.
    Fava M; Rosenbaum JF; MacLaughlin R; Falk WE; Pollack MH; Cohen LS; Jones L; Pill L
    J Psychiatr Res; 1990; 24(2):177-84. PubMed ID: 2120432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant activity of S-adenosylmethionine.
    Caruso I; Fumagalli M; Boccassini L; Sarzi Puttini P; Ciniselli G; Cavallari G
    Lancet; 1984 Apr; 1(8382):904. PubMed ID: 6143204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.
    Mischoulon D; Fava M
    Am J Clin Nutr; 2002 Nov; 76(5):1158S-61S. PubMed ID: 12420702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects.
    Silveri MM; Parow AM; Villafuerte RA; Damico KE; Goren J; Stoll AL; Cohen BM; Renshaw PF
    Biol Psychiatry; 2003 Oct; 54(8):833-9. PubMed ID: 14550683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 5():18-22. PubMed ID: 19909689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial.
    Di Rocco A; Rogers JD; Brown R; Werner P; Bottiglieri T
    Mov Disord; 2000 Nov; 15(6):1225-9. PubMed ID: 11104210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.